The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics-Based Analysis and Review

Overview

Journal J Anal Methods Chem

Publisher Wiley

Specialty Chemistry

Date 2022 Oct 26

PMID 36284547

Authors

Zhiyi Li

Affiliations

Soon will be listed here.

Abstract

With the continuous development of medical science and technology, especially with the advent of the era of precision diagnosis and treatment, molecular biology detection technology is widely valued and applied as an aid to early diagnosis of tuberculosis. The GeneXpert Branching (MTB) technology is a suite of semi-nested real-time fluorescent quantitative PCR in vitro diagnostic technologies developed by Cepheid Inc. It targets the rifampicin resistance gene, rpoB, and can detect both MTB and resistance to rifampicin within 2 h. This review analyzed the papers related to GeneXpert using bibliometric software CiteSpace and Bibliometrix. A total of 151 articles were analyzed, spanning from 2011 to 2021. This bibliometrics-based review summarizes the history of the development of GeneXpert in tuberculosis diagnosis and its current status. Contributions of different countries to the topic, journal analysis, key paper analysis, and clustering of keywords were used to analyze this topic.

Citing Articles

Prevalence of Microbiologically Confirmed Female Genital Tuberculosis in a Tertiary Care Hospital in Faridabad, Haryana, India.

Gunasekaran J, Ranjan R, Karlapudi P, Pandey P, Chichhal K, Gupta S Cureus. 2025; 16(12):e75358.

PMID: 39781157 PMC: 11707633. DOI: 10.7759/cureus.75358.

Multi-drug resistant gene mutation analysis in by molecular techniques.

Sultana M, Alam M, Mistri S, Mostafa Kamal S, Ahsan C, Yasmin M Iran J Microbiol. 2024; 16(4):459-469.

PMID: 39267928 PMC: 11389769. DOI: 10.18502/ijm.v16i4.16304.

The pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by GeneXpert MTB/RIF assay in Tanzania.

Torokaa P, Majigo M, Kileo H, Urio L, Mbwana M, Monah M PLoS One. 2024; 19(8):e0296563.

PMID: 39186753 PMC: 11346956. DOI: 10.1371/journal.pone.0296563.

Rapid Point-of-Care PCR Testing of Drug-Resistant Strains on Endotracheal Aspirate Samples: A Repurposed Effective Tool in the Stepwise Approach of Healthcare-Acquired Pneumonia-A Pilot Study.

Balan A, Bodolea C, Nemes A, Craciun R, Hagau N Int J Mol Sci. 2023; 24(17).

PMID: 37686203 PMC: 10487584. DOI: 10.3390/ijms241713393.

References

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K . Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2009; 48(1):229-37. PMC: 2812290. DOI: 10.1128/JCM.01463-09. View

Phuong N, Thu Anh N, Van Son N, Sintchenko V, Ho J, Fox G . Effect of two alternative methods of pooling sputum prior to testing for tuberculosis with genexpert MTB/RIF. BMC Infect Dis. 2019; 19(1):347. PMC: 6486971. DOI: 10.1186/s12879-019-3778-9. View

Munoz L, Moure R, Porta N, Gonzalez L, Guerra R, Alcaide F . GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?. Diagn Microbiol Infect Dis. 2013; 75(3):325-6. DOI: 10.1016/j.diagmicrobio.2012.11.011. View

Stevens W, Scott L, Noble L, Gous N, Dheda K . Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control. Microbiol Spectr. 2017; 5(1). PMC: 11687441. DOI: 10.1128/microbiolspec.TBTB2-0040-2016. View

Saeed M, Hussain S, Riaz S, Rasheed F, Ahmad M, Iram S . GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?. Open Life Sci. 2021; 15(1):458-465. PMC: 7874587. DOI: 10.1515/biol-2020-0052. View

Marlowe E, Novak-Weekley S, Cumpio J, Sharp S, Momeny M, Babst A . Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol. 2011; 49(4):1621-3. PMC: 3122817. DOI: 10.1128/JCM.02214-10. View

Sanchez-Cabral O, Santillan-Diaz C, Flores-Bello A, Herrera-Ortega M, Sandoval-Gutierrez J, Santillan-Doherty P . GeneXpert MTB/RIF assay with transbronchial lung cryobiopsy for Mycobacterium tuberculosis diagnosis. Ann Transl Med. 2020; 8(6):351. PMC: 7186622. DOI: 10.21037/atm.2020.02.100. View

Evans C . GeneXpert--a game-changer for tuberculosis control?. PLoS Med. 2011; 8(7):e1001064. PMC: 3144196. DOI: 10.1371/journal.pmed.1001064. View

Boehme C, Nabeta P, Hillemann D, Nicol M, Shenai S, Krapp F . Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010; 363(11):1005-15. PMC: 2947799. DOI: 10.1056/NEJMoa0907847. View

10.

Hillemann D, Rusch-Gerdes S, Boehme C, Richter E . Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol. 2011; 49(4):1202-5. PMC: 3122824. DOI: 10.1128/JCM.02268-10. View

11.

Hiruy N, Melese M, Habte D, Jerene D, Gashu Z, Alem G . Comparison of the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test. Int J Infect Dis. 2018; 71:4-8. DOI: 10.1016/j.ijid.2018.03.011. View

12.

Walters E, Goussard P, Bosch C, Hesseling A, Gie R . GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: a pilot study. Pediatr Pulmonol. 2013; 49(11):1133-7. DOI: 10.1002/ppul.22970. View

13.

Mao S, Fu L, Yin C, Liu X, Karimi-Maleh H . The role of electrochemical biosensors in SARS-CoV-2 detection: a bibliometrics-based analysis and review. RSC Adv. 2022; 12(35):22592-22607. PMC: 9372877. DOI: 10.1039/d2ra04162f. View

14.

Gebretsadik D, Ahmed N, Kebede E, Mohammed M, Belete M . Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia. Infect Drug Resist. 2020; 13:1507-1516. PMC: 7247715. DOI: 10.2147/IDR.S248059. View

15.

Shenai S, Amisano D, Ronacher K, Kriel M, Banada P, Song T . Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay. J Clin Microbiol. 2013; 51(12):4161-6. PMC: 3838083. DOI: 10.1128/JCM.01743-13. View

16.

Sweileh W, AbuTaha A, Sawalha A, Al-Khalil S, Al-Jabi S, Zyoud S . Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015). Multidiscip Respir Med. 2017; 11:45. PMC: 5225617. DOI: 10.1186/s40248-016-0081-0. View

17.

Cuong N, Ngoc N, Hoa N, Dat V, Nhung N . GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis. PLoS One. 2021; 16(7):e0253961. PMC: 8259960. DOI: 10.1371/journal.pone.0253961. View

18.

Saeed M, Iram S, Hussain S, Ahmed A, Akbar M, Aslam M . GeneXpert: A new tool for the rapid detection of rifampicin resistance in mycobacterium tuberculosis. J Pak Med Assoc. 2017; 67(2):270-274. View

19.

Jin M, Liu J, Wu W, Zhou Q, Fu L, Zare N . Relationship between graphene and pedosphere: A scientometric analysis. Chemosphere. 2022; 300:134599. DOI: 10.1016/j.chemosphere.2022.134599. View

20.

Horne D, Kohli M, Zifodya J, Schiller I, Dendukuri N, Tollefson D . Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019; 6:CD009593. PMC: 6555588. DOI: 10.1002/14651858.CD009593.pub4. View